Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model
about
Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic ratsDevelopment and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progressionRegulation of Cellular Identity in CancerRPL38, FOSL1, and UPP1 are predominantly expressed in the pancreatic ductal epithelium.Biology of urothelial tumorigenesis: insights from genetically engineered mice.Current animal models of bladder cancer: Awareness of translatability (Review)Generation and characterization of a transgenic mouse model for pancreatic cancer.Development of a syngeneic mouse model of epithelial ovarian cancer.T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesisUroplakins in urothelial biology, function, and diseaseProlactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic miceModelling bladder cancer in mice: opportunities and challenges.High-grade urothelial carcinoma in a kidney transplant recipient with BK virus infectionSimian virus 40 transformation, malignant mesothelioma and brain tumors.Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis.Urothelial tumorigenesis: a tale of divergent pathways.Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization.Animal models of malignant mesothelioma.Estrogen receptor-positive mammary tumorigenesis in TGFalpha transgenic mice progresses with progesterone receptor loss.p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice.The genomic revolution and endocrine pathology.Mouse orthotopic models for bladder cancer research.Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis.Induction of tunica vaginalis mesotheliomas in rats by xenobiotics.Archetype and Rearranged Non-coding Control Regions in Urothelial Bladder Carcinoma of Immunocompetent Individuals.Exploring molecular genetics of bladder cancer: lessons learned from mouse modelsBK Polyomavirus Infection and Renourinary Tumorigenesis.Transgenic Mouse Models of SV40-Induced Cancer.Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model.Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals.Cell-specific transgene expression from a widely transcribed promoter using Cre/lox in mice.Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.BK virus-associated collecting duct carcinoma of the renal allograft in a kidney-pancreas allograft recipient.Understanding the biology of urothelial cancer metastasis.Molecular Subtype-Specific Immunocompetent Models of High-Grade Urothelial Carcinoma Reveal Differential Neoantigen Expression and Response to Immunotherapy
P2860
Q23924152-1A614031-76D0-4966-AB03-48AE55AD467AQ27325140-EC020B54-F839-4496-84F2-2C8B054C2E02Q28086849-92131640-756D-4862-91CD-96566B3597ABQ31147661-C4A8907A-9DB6-4E6D-87D3-75ED770386EAQ33554361-67E291AA-18F8-4B77-99B1-73CD55D27E66Q33962620-E0B47BA5-7FEF-4F58-9DC0-5BE46DA9C1FEQ34037461-0370F9D1-9DE6-4D9E-B569-0E11C6CF6E2BQ34282708-FACAD93C-1798-43E0-80F5-95040A7630DCQ34662543-44C99C55-A560-483C-A691-F08D7C7A5526Q34973621-A61B3BDE-C0B3-46C3-BF9B-7586EEC5A349Q35121912-E69486AC-A2B9-4991-A812-89BC26B6E26AQ35285703-5FA8C03A-B2F0-47CF-8309-4ED5F152E35FQ35573694-B3FC73CF-DC3A-4E0D-A235-DBA53D974A38Q35621800-F8D9F385-DE55-466C-A6FA-3831B31FDC6CQ35689762-94382770-8950-48F8-92EF-23128F06913CQ36234720-E347F740-04B7-48FA-B8D3-009558976025Q36446437-E7BBEE9E-EB8C-45B7-A995-63803BA7D1E5Q36571864-27738E42-B08A-41F5-B929-0A0C539D80C8Q36983423-B07A53AE-36E6-4067-8C57-BFFB043D5988Q37061038-13EA1067-4925-48A4-8A69-19F646AFA161Q37256497-9C98E7A5-48E9-4DE8-B781-282237B0C763Q37457056-75AC048F-ACE7-4FAE-9F1F-EDEFEAA71E2FQ37480033-849C7603-C7E2-49B6-ADAD-0AECF71A761FQ37526974-8764C01E-CC92-4AF3-ACC6-3A757692C6F0Q37570005-245C8B8E-3985-4A7E-ADB8-DE2069DA5140Q37994164-F29C6A54-06E3-4D2D-B0C9-C8CBDFA55D57Q38687133-1A412DE7-E6F4-4512-9B85-0769A551A836Q38795316-F2439588-99FC-4F95-A527-5C7F42D75932Q42379859-0F076EC6-913C-457C-B0BD-A460F8B86243Q45419938-8B907064-7AA8-4C8A-9316-D9D40B36B951Q53390973-DB81791E-9D67-4649-B559-B7F73DAC3CB4Q53978706-BF3E25F0-A24B-4578-9CF6-030630D2FC01Q54245382-3EA06579-3F61-4F93-8FFC-F3B97A93C28DQ55126311-9EBECC92-3379-460C-B0C4-B1AED9426520Q57175925-2FF49C06-F09A-4563-B6E9-257A11CFB095
P2860
Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Highly invasive transitional c ...... antigen transgenic mouse model
@ast
Highly invasive transitional c ...... antigen transgenic mouse model
@en
type
label
Highly invasive transitional c ...... antigen transgenic mouse model
@ast
Highly invasive transitional c ...... antigen transgenic mouse model
@en
prefLabel
Highly invasive transitional c ...... antigen transgenic mouse model
@ast
Highly invasive transitional c ...... antigen transgenic mouse model
@en
P2860
P1476
Highly invasive transitional c ...... antigen transgenic mouse model
@en
P2093
E P Sandgren
P J Grippo
P2860
P304
P356
10.1016/S0002-9440(10)64594-4
P407
P577
2000-09-01T00:00:00Z